Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The Food and Drug Administration (FDA or Agency) is requesting nominations for qualified individuals to serve as voting members of FDA's standing public advisory committees and ...
The Food and Drug Administration (FDA or Agency) is requesting nominations for qualified individuals to serve as voting members of FDA's standing public advisory committees and panels (collectively, advisory committees). This notice covers scientific, technical, professional, and other voting-member positions in which appointees serve as individuals rather than as designated representatives; it does not solicit nominations for consumer representative or industry representative positions. FDA will consider nominations for current and future vacancies as they arise. FDA encourages nominations of all appropriately qualified candidates whose expertise and perspectives would contribute to the work and balanced composition of its advisory committees.
DATES:
FDA accepts nominations on a continuing basis. Nominations received on or before November 30, 2026 will be given first consideration for current and near-term vacancies. Nominations received after that date will be considered as later vacancies arise.
Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 3215, Silver Spring, MD 20993-0002, 301-796-8220,
ACOMSSubmissions@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background and Scope
FDA uses public advisory committees to obtain independent expert advice on scientific, technical, and policy matters within the Agency's responsibilities.
This notice applies to voting-member positions in which members serve as individuals and not as representatives of a nominating or affiliated group, consistent with 21 CFR 14.82(d). It does not apply to positions designated to represent consumer or industry interests. Separate statutes, regulations, charters, or notices may govern those representative positions or other committee-specific nomination and selection processes. If a committee-
( printed page 62528)
specific statute or charter establishes qualifications, composition, nomination, or selection requirements, those requirements control. This notice does not replace the solicitation of nominations required when FDA establishes a new advisory committee under 21 CFR 14.82(b).
For medical device classification panels, this annual notice also provides the opportunity described in section 513(b)(5)(D) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360c(b)(5)(D)) for patients, representatives of patients, and sponsors of medical devices that may be specifically subject to review by a classification panel to recommend individuals with appropriate expertise for voting-member positions.
II. Criteria for Voting Members and Appointment Status
In general, nominees should demonstrate subject-matter expertise relevant to one or more FDA advisory committees, the ability to interpret complex scientific or technical information, an understanding of the public health significance of the matters before the committee, and the ability to provide objective and independent advice. FDA will consider the expertise, experience, professional disciplines, and points of view needed for the functions of the particular committee and to support fairly balanced membership.
Voting members serve as individuals and not as representatives of any group or organization that nominated them or with which they are affiliated. Generally, non-Federal voting members are appointed as special Government employees and are subject to applicable Federal ethics and conflict-of-interest requirements. Federal employees may serve as regular Government employees in their official capacities when authorized for the particular committee and position. Certain committees or positions may be governed by different statutory, regulatory, or charter provisions. FDA will determine the appropriate appointment status for each position.
Members generally are invited to serve for overlapping terms of up to 4 years, or for a shorter period at the discretion of the appointing official, subject to the applicable statutes, regulations, and committee charter.
III. Nomination Procedures
Any interested person may nominate one or more qualified individuals for membership on one or more of the advisory panels or advisory committees. Self-nominations are also accepted. Nominations must include a current, complete résumé or curriculum vitae for each nominee. Nominations must also specify the advisory committee for which the nominee is recommended. Additionally, nominations must acknowledge that the nominee is aware of the nomination unless self-nominated. FDA will ask potential candidates to provide detailed information concerning such matters related to financial holdings, employment, and research grants and/or contracts to permit evaluation of possible sources of conflicts of interest. Only U.S. Citizens, non-citizen U.S. Nationals, and Permanent Residents may apply for service as a committee member.
This notice is issued under the Federal Advisory Committee Act (5 U.S.C. 1001et seq.) and 21 CFR part 14, relating to advisory committees.
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
Use this for formal legal and research references to the published document.
91 FR 62527
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees,” thefederalregister.org (October 1, 2026), https://thefederalregister.org/documents/2026-20063/request-for-nominations-for-voting-members-of-food-and-drug-administration-advisory-committees.
www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm
www.fda.gov/advisory-committees/advisory-committee-membership/applying-membership-fda-advisory-committees
21 CFR 14.82(d)
21 U.S.C. 360c(b)(5)(D)